222 related articles for article (PubMed ID: 38824133)
21. Systemic features of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a monogenic small vessel disease.
Pelzer N; Hoogeveen ES; Haan J; Bunnik R; Poot CC; van Zwet EW; Inderson A; Fogteloo AJ; Reinders MEJ; Middelkoop HAM; Kruit MC; van den Maagdenberg AMJM; Ferrari MD; Terwindt GM
J Intern Med; 2019 Mar; 285(3):317-332. PubMed ID: 30411414
[TBL] [Abstract][Full Text] [Related]
22. RVCL-S and CADASIL display distinct impaired vascular function.
de Boer I; Stam AH; Buntinx L; Zielman R; van der Steen I; van den Maagdenberg AMJM; de Koning EJP; Ferrari MD; de Hoon JN; Terwindt GM
Neurology; 2018 Sep; 91(10):e956-e963. PubMed ID: 30076273
[TBL] [Abstract][Full Text] [Related]
23. High clinical heterogeneity in a Chinese pedigree of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S).
Xie N; Sun Q; Yang J; Zhou Y; Xu H; Zhou L; Zhou Y
Orphanet J Rare Dis; 2021 Jan; 16(1):56. PubMed ID: 33516249
[TBL] [Abstract][Full Text] [Related]
24. Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic manifestations (RVCL-S): An update on basic science and clinical perspectives.
Wilms AE; de Boer I; Terwindt GM
Cereb Circ Cogn Behav; 2022; 3():100046. PubMed ID: 36324396
[TBL] [Abstract][Full Text] [Related]
25. Circulating Endothelial Markers in Retinal Vasculopathy With Cerebral Leukoencephalopathy and Systemic Manifestations.
Pelzer N; Bijkerk R; Reinders MEJ; van Zonneveld AJ; Ferrari MD; van den Maagdenberg AMJM; Eikenboom J; Terwindt GM
Stroke; 2017 Dec; 48(12):3301-3307. PubMed ID: 29114091
[TBL] [Abstract][Full Text] [Related]
26. The 3'-5' DNA exonuclease TREX1 directly interacts with poly(ADP-ribose) polymerase-1 (PARP1) during the DNA damage response.
Miyazaki T; Kim YS; Yoon J; Wang H; Suzuki T; Morse HC
J Biol Chem; 2014 Nov; 289(47):32548-58. PubMed ID: 25278026
[TBL] [Abstract][Full Text] [Related]
27. The TREX1 double-stranded DNA degradation activity is defective in dominant mutations associated with autoimmune disease.
Lehtinen DA; Harvey S; Mulcahy MJ; Hollis T; Perrino FW
J Biol Chem; 2008 Nov; 283(46):31649-56. PubMed ID: 18805785
[TBL] [Abstract][Full Text] [Related]
28. Human disease phenotypes associated with mutations in TREX1.
Rice GI; Rodero MP; Crow YJ
J Clin Immunol; 2015 Apr; 35(3):235-43. PubMed ID: 25731743
[TBL] [Abstract][Full Text] [Related]
29. Imbalance of the von Willebrand Factor - ADAMTS-13 axis in patients with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S).
Braune M; Metelmann M; de Fallois J; Pfrepper C; Barrantes-Freer A; Hiller GGR; Unger S; Seelow E; Halbritter J; Pelz JO
Neurol Res Pract; 2024 Jun; 6(1):32. PubMed ID: 38898536
[TBL] [Abstract][Full Text] [Related]
30. TREX1 - Apex predator of cytosolic DNA metabolism.
Simpson SR; Hemphill WO; Hudson T; Perrino FW
DNA Repair (Amst); 2020 Oct; 94():102894. PubMed ID: 32615442
[TBL] [Abstract][Full Text] [Related]
31. Dominant mutation of the TREX1 exonuclease gene in lupus and Aicardi-Goutieres syndrome.
Fye JM; Orebaugh CD; Coffin SR; Hollis T; Perrino FW
J Biol Chem; 2011 Sep; 286(37):32373-82. PubMed ID: 21808053
[TBL] [Abstract][Full Text] [Related]
32. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease.
Yang YG; Lindahl T; Barnes DE
Cell; 2007 Nov; 131(5):873-86. PubMed ID: 18045533
[TBL] [Abstract][Full Text] [Related]
33. New roles for the major human 3'-5' exonuclease TREX1 in human disease.
Kavanagh D; Spitzer D; Kothari PH; Shaikh A; Liszewski MK; Richards A; Atkinson JP
Cell Cycle; 2008 Jun; 7(12):1718-25. PubMed ID: 18583934
[TBL] [Abstract][Full Text] [Related]
34. TREX1 p.A129fs and p.Y305C variants in a large multi-ethnic cohort of CADASIL-like unrelated patients.
Foddis M; Blumenau S; Holtgrewe M; Paquette K; Westra K; Alonso I; Macario MDC; Morgadinho AS; Velon AG; Santo G; Santana I; Mönkäre S; Kuuluvainen L; Schleutker J; Pöyhönen M; Myllykangas L; Pavlovic A; Kostic V; Dobricic V; Lohmann E; Hanagasi H; Santos M; Guven G; Bilgic B; Bras J; Beule D; Dirnagl U; Guerreiro R; Sassi C
Neurobiol Aging; 2023 Mar; 123():208-215. PubMed ID: 36586737
[TBL] [Abstract][Full Text] [Related]
35. Compromised nuclear envelope integrity drives TREX1-dependent DNA damage and tumor cell invasion.
Nader GPF; Agüera-Gonzalez S; Routet F; Gratia M; Maurin M; Cancila V; Cadart C; Palamidessi A; Ramos RN; San Roman M; Gentili M; Yamada A; Williart A; Lodillinsky C; Lagoutte E; Villard C; Viovy JL; Tripodo C; Galon J; Scita G; Manel N; Chavrier P; Piel M
Cell; 2021 Sep; 184(20):5230-5246.e22. PubMed ID: 34551315
[TBL] [Abstract][Full Text] [Related]
36. Human three prime exonuclease TREX1 is induced by genotoxic stress and involved in protection of glioma and melanoma cells to anticancer drugs.
Tomicic MT; Aasland D; Nikolova T; Kaina B; Christmann M
Biochim Biophys Acta; 2013 Aug; 1833(8):1832-43. PubMed ID: 23578789
[TBL] [Abstract][Full Text] [Related]
37. Defects in DNA degradation revealed in crystal structures of TREX1 exonuclease mutations linked to autoimmune disease.
Bailey SL; Harvey S; Perrino FW; Hollis T
DNA Repair (Amst); 2012 Jan; 11(1):65-73. PubMed ID: 22071149
[TBL] [Abstract][Full Text] [Related]
38. Human Three Prime Repair Exonuclease 1 Promotes HIV-1 Integration by Preferentially Degrading Unprocessed Viral DNA.
Davids BO; Balasubramaniam M; Sapp N; Prakash P; Ingram S; Li M; Craigie R; Hollis T; Pandhare J; Dash C
J Virol; 2021 Aug; 95(17):e0055521. PubMed ID: 34105995
[TBL] [Abstract][Full Text] [Related]
39. Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study.
Wang WX; Spiegelman D; Rao PK; Ford AL; Apte RS
J Clin Invest; 2024 May; 134(12):. PubMed ID: 38950286
[TBL] [Abstract][Full Text] [Related]
40. Genotype-Phenotype Correlation and Functional Insights for Two Monoallelic
Amico G; Hemphill WO; Severino M; Moratti C; Pascarella R; Bertamino M; Napoli F; Volpi S; Rosamilia F; Signa S; Perrino F; Zedde M; Ceccherini I; On Behalf Of The Gaslini Stroke Study Group
Genes (Basel); 2022 Jun; 13(7):. PubMed ID: 35885962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
